At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01951 JXR
Closed Labour Day 04-30 16:08:13
2.390
-0.030
-1.24%
High2.420Low2.370Vol11.57M
Open2.390D1 Closing2.420Amplitude2.07%
Mkt Cap6.46BTradable Cap6.46BTotal Shares2.71B
T/O27.63MT/O Rate0.43%Tradable Shares2.71B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
JXR Completes 19.67 Million-Share Buyback Worth HK$47.05 Million; Issued Capital Remains at 2.71 B Shares
Bulletin Express  ·  04-30 19:23
JXR Completes 19.67 Million-Share Buyback Worth HK$47.05 Million; Issued Capital Remains at 2.71 B Shares
JXR Spends HK$4.78 Million to Buy Back 2 Million Shares on April 30
Stock News  ·  04-30 19:22
JXR Spends HK$4.78 Million to Buy Back 2 Million Shares on April 30
Jinxin Fertility files HKEX return disclosing share repurchase at HKD 2.4 per share
Reuters  ·  04-30 19:20
Jinxin Fertility files HKEX return disclosing share repurchase at HKD 2.4 per share
JXR repurchases 2.07 million shares; 17.67 million now awaiting cancellation after HK$42.27 million buy-back since late March
Bulletin Express  ·  04-28
JXR repurchases 2.07 million shares; 17.67 million now awaiting cancellation after HK$42.27 million buy-back since late March
Jinxin Fertility files HKEX return, discloses share buyback at HKD 2.42-2.38
Reuters  ·  04-28
Jinxin Fertility files HKEX return, discloses share buyback at HKD 2.42-2.38
锦欣生殖2025年业绩：净亏损9.84亿元，多区域扩张与核心生殖业务持续推进
Bulletin Express  ·  04-23
锦欣生殖2025年业绩：净亏损9.84亿元，多区域扩张与核心生殖业务持续推进
JXR’s 2025 Sustainability Report Highlights Robust Governance, Medical Innovation and Firm ESG Targets
Bulletin Express  ·  04-23
JXR’s 2025 Sustainability Report Highlights Robust Governance, Medical Innovation and Firm ESG Targets
Jinxin Fertility publishes 2025 annual report
Reuters  ·  04-23
Jinxin Fertility publishes 2025 annual report
JXR repurchases 0.03% of shares on 21 Apr; pending cancellations rise to 15.60 million
Bulletin Express  ·  04-21
JXR repurchases 0.03% of shares on 21 Apr; pending cancellations rise to 15.60 million
Jinxin Fertility files HKEX return disclosing share repurchase at HKD 2.46
Reuters  ·  04-21
Jinxin Fertility files HKEX return disclosing share repurchase at HKD 2.46
JXR repurchases 3.23 million shares for HK$7.89 million; 54.46 million shares bought back under existing mandate
Bulletin Express  ·  04-20
JXR repurchases 3.23 million shares for HK$7.89 million; 54.46 million shares bought back under existing mandate
JXR Allocates HK$7.886 Million for Share Buyback on April 20
Stock News  ·  04-20
JXR Allocates HK$7.886 Million for Share Buyback on April 20
JXR Allocates HK$4.96 Million to Repurchase 2.066 Million Shares on April 15
Stock News  ·  04-15
JXR Allocates HK$4.96 Million to Repurchase 2.066 Million Shares on April 15
JXR repurchases 3.20 million shares; outstanding buybacks awaiting cancellation reach 9.51 million
Bulletin Express  ·  04-10
JXR repurchases 3.20 million shares; outstanding buybacks awaiting cancellation reach 9.51 million
JXR Allocates HK$7.89 Million for Share Buyback on April 10
Stock News  ·  04-10
JXR Allocates HK$7.89 Million for Share Buyback on April 10
Jinxin Fertility files HKEX next-day return disclosing HKD 2.47 share buyback price
Reuters  ·  04-10
Jinxin Fertility files HKEX next-day return disclosing HKD 2.47 share buyback price
JXR trims outstanding shares by 52.66 million via HKD 2.53 buyback and treasury cancellation
Bulletin Express  ·  04-09
JXR trims outstanding shares by 52.66 million via HKD 2.53 buyback and treasury cancellation
JXR Cancels 39.66 Million Repurchased Shares on April 9
Stock News  ·  04-09
JXR Cancels 39.66 Million Repurchased Shares on April 9
Jinxin Fertility files HKEX next-day return disclosing buyback at HKD 2.53/share
Reuters  ·  04-09
Jinxin Fertility files HKEX next-day return disclosing buyback at HKD 2.53/share
JXR Maintains Capital Structure in March 2026; 45.97 Million Repurchased Shares Pending Cancellation
Bulletin Express  ·  04-09
JXR Maintains Capital Structure in March 2026; 45.97 Million Repurchased Shares Pending Cancellation
No data available

Introduction

Company Name.
JXR
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Jinxin Fertility Group Ltd is an investment holding company principally engaged in the provision of in-vitro fertilization (IVF) services. Through its subsidiaries, the Company mainly provides assisted reproductive services, management services, ambulatory surgery center facilities services, ancillary medical services, obstetrics, gynecology and pediatrics medical services, as well as the sales of medical consumables and equipment. The Company mainly provides its services in both China and the United States.
Issue price:
--